LEADER 01248nam 2200409 450 001 9910815147703321 005 20230807213428.0 010 $a92-0-117719-4 035 $a(CKB)3710000001364576 035 $a(MiAaPQ)EBC4853287 035 $a(Au-PeEL)EBL4853287 035 $a(CaPaEBR)ebr11384212 035 $a(OCoLC)987087860 035 $a(EXLCZ)993710000001364576 100 $a20170605h20152015 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aClinical PET/CT atlas $ea casebook of imaging in oncology /$fInternational Atomic Energy Agency 210 1$aVienna, [Austria] :$cInternational Atomic Energy Agency,$d2015. 210 4$d©2015 215 $a1 online resource (220 pages) $ccolor illustrations, photographs 225 1 $aIAEA Human Health Series,$x2075-3772 ;$vNumber 32 311 $a92-0-101115-6 410 0$aIAEA human health series ;$vNumber 32. 606 $aTomography, Emission 615 0$aTomography, Emission. 676 $a616.07575 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910815147703321 996 $aClinical PET$93925801 997 $aUNINA LEADER 01576nas 2200469-- 450 001 9910224015303321 005 20241221111430.0 035 $a(CKB)963018046605 035 $a(CONSER)sn-79000667- 035 $a(MiFhGG)5086 035 $a(EXLCZ)99963018046605 100 $a20790718a19799999 k-- a 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 04$aThe Mississippi business journal 210 $a[Jackson, Miss.]$c[Downhome Publications, etc.] 215 $a1 online resource 311 08$aPrint version: The Mississippi business journal. (DLC)sn 79000667 (OCoLC)5184368 0195-0002 517 3 $aBusiness journal 531 $aMISSISSIPPI BUSINESS JOURNAL 531 $aMISSISSIPPI BUSINESS JOURNAL, THE 606 $aBusiness$vPeriodicals 606 $aBusiness$2fast$3(OCoLC)fst00842262 606 $aCommerce$2fast$3(OCoLC)fst00869279 606 $aEconomic history$2fast$3(OCoLC)fst00901974 607 $aMississippi$xEconomic conditions$vPeriodicals 607 $aMississippi$xCommerce$vPeriodicals 607 $aMississippi$2fast$1https://id.oclc.org/worldcat/entity/E39PBJgxpvDfT9yvtDg4ddFR8C 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aBusiness 615 7$aBusiness. 615 7$aCommerce. 615 7$aEconomic history. 712 02$aInformation Access Company. 906 $aNEWSPAPER 912 $a9910224015303321 920 $aexl_impl conversion 996 $aThe Mississippi business journal$91967454 997 $aUNINA LEADER 03738nam 22006255 450 001 9910254509803321 005 20200703234721.0 010 $a3-319-27880-0 024 7 $a10.1007/978-3-319-27880-3 035 $a(CKB)3710000000627478 035 $a(EBL)4470896 035 $a(SSID)ssj0001654116 035 $a(PQKBManifestationID)16432924 035 $a(PQKBTitleCode)TC0001654116 035 $a(PQKBWorkID)14983058 035 $a(PQKB)11392261 035 $a(DE-He213)978-3-319-27880-3 035 $a(MiAaPQ)EBC4470896 035 $a(PPN)192774271 035 $a(EXLCZ)993710000000627478 100 $a20160331d2016 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aOncological PET/CT with Histological Confirmation /$fedited by Juliano Cerci, Stefano Fanti, Dominique Delbeke 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (100 p.) 300 $aDescription based upon print version of record. 311 $a3-319-27878-9 320 $aIncludes bibliographical references and index. 327 $aPART I. Biopsy guided PET/CT: Principle of biopsy guided imaging.- FDG PET/CT to guide biopsy: methods.- FDG PET/CT to guide biopsy: type of acess.- PART II. FDG PET/CT in lymphoma: Need of biopsy in lymphoma.- FDG PET/CT to guide biopsy in lymphoma: results.- PART III. FDG PET/CT in pancreatic lesions:Need of biopsy in pancreatic lesions.- FDG PET/CT to guide biopsy in pancreatic lesions: results.- PART IV. FDG PEM in breast lessions: Need of biopsy in breast lesions.- FDG PEM to guide biopsy in breast lesions: results -- PART V. PET/CT and CNS malignancies: Need of biopsy in CNS malignancies -- FDG PET/CT to guide biopsy in CNS: results -- PART VI. PET/CT and prostate cancer -- Choline PET/CT to guide biopsy in prostate cancer diagnosis -- PART VII. FLT PET/CT in cancer diagnosis: FLT PET/CT in cancer diagnosis: results. 330 $aThis book reviews the important new field of PET/CT-guided biopsy, which is of potential value in optimizing the diagnostic yield of biopsies. The role of this technology is examined in a range of malignancies, including lymphoma, pancreatic, breast cancer and CNS malignancies. True positive and false positive cases are presented and discussed, and many aspects of PET and pathology are addressed. The book describes many case presentations illustrated with mostly 18F-FDG PET/CT images, but also other PET radiopharmaceuticals such as 18F-FLT. The three editors are expert nuclear medicine physicians from Europe and North and South America, and the range of experiences gained in using PET/CT across the globe is reflected in the book. 606 $aNuclear medicine 606 $aOncology 606 $aPathology 606 $aNuclear Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H29048 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X 615 0$aNuclear medicine. 615 0$aOncology. 615 0$aPathology. 615 14$aNuclear Medicine. 615 24$aOncology. 615 24$aPathology. 676 $a610 702 $aCerci$b Juliano$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aFanti$b Stefano$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aDelbeke$b Dominique$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910254509803321 996 $aOncological PET$92518515 997 $aUNINA